Champions Oncology Q4 2024 Adj EPS $0.01 Beats $(0.16) Estimate, Sales $14.001M Beat $12.692M Estimate

Author: Benzinga Newsdesk | July 18, 2024 05:05pm
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.16) by 106.25 percent. This is a 105.88 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $14.001 million which beat the analyst consensus estimate of $12.692 million by 10.31 percent. This is a 7.11 percent increase over sales of $13.071 million the same period last year.

Posted In: CSBR